Our meals are ready to enjoy and portion perfect
As more people employ Ozempic to manage diabetes and speculate its efficacy in weight loss, reports to the FDA regarding potential side effects, particularly relating to mental health, have been on the ascent
Can I switch between different GLP-1 medications if one doesn't work
Zannad F., Cannon C.P., Cushman W.C., et al
Dec 4 2015;175:21-9
A realistic timeline, based on where the Phase 3 programme is now, looks like this: FDA submission in the U.S.: late 2026 or 2027 FDA approval: 2027 or 2028 UK MHRA review: typically 12 to 24 months after FDA approval NHS access through a NICE appraisal: a separate process, usually 12 to 24 months after MHRA approval The earliest UK private access through online pharmacies, mirroring how Mounjaro and Wegovy first launched here, is likely 2027 or 2028